Literature DB >> 10425306

Long-term control of multiple lung metastases from osteosarcoma obtained by conventional radiotherapy: a case report.

Y Shibamoto1, N Horii, M Takahashi.   

Abstract

An osteosarcoma patient whose lung metastases were successfully treated with radiotherapy is reported. The patient developed multiple lung metastases repeatedly after successful treatment of the primary lesion in his femur. Resection of the lung metastases was performed 5 times during 4 years (12 metastatic nodules in total). One of the specimens was evaluated using the micronucleus test, which suggested moderate radiosensitivity of the tumor. He further developed 2 metastases 19 months after the last operation, and these tumors were treated with conventional radiation with 60 and 64 Gy, respectively. The tumors regressed slowly after radiation and disappeared later. Although he developed another lung metastasis 2 years later, the lesion was also treated with radiation with 66 Gy and all of the 3 irradiated tumors are now under control at 43 months after the first radiotherapy and 15 months after the second one. Our experience would suggest that some (at least) metastatic osteosarcomas have reasonable radiosensitivity, and radiation therapy including radiosurgery may be a good alternative to surgery in patients for whom operation is not indicated.

Entities:  

Mesh:

Year:  1999        PMID: 10425306     DOI: 10.3892/or.6.5.1085

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  Orbital metastasis: a rare presentation of osteosarcoma.

Authors:  Suresh V S Attili; Ankit Jain; Kamal V Saini; Ullas Batra; K Govind Babu; K V Sajeevan; Siddarth Biswas
Journal:  Int Ophthalmol       Date:  2007-10-23       Impact factor: 2.031

2.  Effects of Arsenic Trioxide on Minor Progressive High-Grade Osteosarcoma of the Extremities Metastatic to the Lung: Results of 39 Patients Treated in a Single Institution.

Authors:  Lu Xie; Wei Guo; Xiaodong Tang; Yi Yang; Jie Xu
Journal:  Case Rep Oncol       Date:  2016-10-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.